# Genome Therapeutics (Genome Therapeutics Ltd)

Private limited company registered in London, classed under “Research and experimental development on biotechnology”.

- Company number: 12392992
- Status: Active
- Type: Private limited company
- Incorporated: 8 January 2020
- Registered office: Regent House, 316 Beulah Hill, London, SE19 3HF
- Location: London
- Activity: Research and experimental development on biotechnology

## Latest filed profit

Profit after tax in the year to 30 June 2021: **loss of £27.2k**, from its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Genome Therapeutics do?

Private limited company registered in London, classed under “Research and experimental development on biotechnology”.

### How much turnover does Genome Therapeutics make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/genome-therapeutics-12392992

### Is Genome Therapeutics profitable?

Genome Therapeutics's profit isn't public: small companies may file without a profit and loss account.

### How many people work at Genome Therapeutics?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/genome-therapeutics-12392992

### Where is Genome Therapeutics based?

Its registered office is Regent House, 316 Beulah Hill, London, SE19 3HF, in London.

### When was Genome Therapeutics founded?

Genome Therapeutics Ltd was incorporated on 8 January 2020.

### Is Genome Therapeutics still trading?

The register lists Genome Therapeutics Ltd as active.

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/genome-therapeutics-12392992